|
Polycystic ovary syndrome and prolactinoma association
|
18 January 2023 |
|
Prolactinoma and other head and neck tumors after scalp irradiation
|
12 January 2023 |
|
An attempt at conservative treatment in selected cases of type I endometrial carcinoma (stage I a/G1) in young women
|
11 January 2023 |
|
Initial staging of lymphoma with octreotide and other receptor imaging agents
|
06 January 2023 |
|
Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study
|
05 January 2023 |
|
Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas
|
04 January 2023 |
|
Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis
|
20 December 2022 |
|
Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion
|
19 December 2022 |
|
Bromocriptine reverses P-glycoprotein-mediated multidrug resistance in tumor cells
|
23 November 2022 |
|
Octreotide LAR: safety and tolerability issues
|
17 November 2022 |